Digestive Remedies in Greece

Digestive Remedies in Greece

Shrinking disposable income and the publication of the so-called 'negative' list of non-reimbursable prescription-only drugs in May 2011 are the two events which continue to have the most significant effect on value sales of digestive remedies. Shrinking disposable income levels pushed Greek consumers to turn to reimbursable prescription-only Rx antacids. Meanwhile the cessation of reimbursement for prescription-only laxatives in May 2011 favoured OTC laxatives, whilst significant price...

Euromonitor International's Digestive Remedies in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Digestive Remedies market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market's major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

• DIGESTIVE REMEDIES IN GREECE
  • Headlines
  • Trends
  • Switches
  • Competitive Landscape
  • Prospects
  • Category Data
    • Table 1 Sales of Digestive Remedies by Category: Value 2007-2012
    • Table 2 Sales of Digestive Remedies by Category: % Value Growth 2007-2012
    • Table 3 Digestive Remedies Company Shares by Value 2008-2012
    • Table 4 Digestive Remedies Brand Shares by Value 2009-2012
    • Table 5 Forecast Sales of Digestive Remedies by Category: Value 2012-2017
    • Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2012-2017
  • Executive Summary
  • Consumer Health Declines Amidst Recession
  • Dysfunction in the Pharmacy Channel Influences the Market
  • Rearrangements in Market Shares for Vitamins and Dietary Supplements
  • Chemists/pharmacists Dominate Value Sales in Consumer Health
  • Price Liberation and Switches To Shape Future Performance
  • Key Trends and Developments
  • Pharmacies Severely Hit in 2012
  • Liberation of OTC Prices: A Long-standing Demand of the Industry Under Discussion
  • Rise in Self-medication and Increasing Importance of Pharmacists Amidst Recession
  • Vitamins and Dietary Supplements: From General Lifestyle Towards More Direct Needs
  • Recession Slows Down Development of Herbal/traditional Products
  • Market Indicators
    • Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
    • Table 8 Life Expectancy at Birth 2007-2012
  • Market Data
    • Table 9 Sales of Consumer Health by Category: Value 2007-2012
    • Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
    • Table 11 Consumer Health Company Shares 2008-2012
    • Table 12 Consumer Health Brand Shares 2009-2012
    • Table 13 Penetration of Private Label by Category 2007-2012
    • Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
    • Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
    • Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
    • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Self-medication/self-care and Preventative Medicine
  • Switches
    • Summary 1 OTC: Switches 2010-2012
  • Sources
    • Summary 2 Research Sources